Immune globulin intravenous (IGIV, for injection into a vein) is used to treat primary immunodeficiency.IGIV is also used to increase platelets (blood clotting cells) in people with immune thrombocytopenic purpura.IGIV is also used in to help prevent certain infections in people with B-cell chronic lymphocytic leukemia.IGIV is also used in people with Kawasaki syndrome, to prevent aneurysm caused by a weakening of the main artery in the heart.
We aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Case numbers are resurging in parts of the world where the COVID-19 pandemic was waning, falling in places that saw huge surges recently, and just beginning to rise in previously little-impacted parts of the globe.
Studying and analyzing the impact of Coronavirus COVID-19 on the Immune Globulin Intravenous industry, the report provide in-depth analysis and professtional advices on how to face the post COIVD-19 period.
Market Segment by Product Type
IVIg Liquid
IVIg Powder
Market Segment by Product Application
Immunodeficiency
Autoimmune Disease
Acute Infection
Finally, the report provides detailed profile and data information analysis of leading company.
Baxter
Grifols
CSL
Octapharma
Biotest
Kedrion
Hualan Bio
CNBG
Shanghai RAAS
CBPO
LFB Group
BPL
Sichuan Yuanda Shuyang
Insights and Tools:
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
Product values and regional markets are estimated by market analyst, data analyst and people from related industry, based on companys' revenue and applications market respectively.
The data sources include but not limited to reports of companys,international organizations and governments, MMI market surveys,and related industry news.
Analyses of global market trends, with historical data, estimates for 2022 and projections of compound annual growth rates (CAGRs) through 2027
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
In addition, the report provides insight into main drivers,challenges,opportunities and risk of the market and strategies of suppliers. Key players are profiled as well with their market shares in the global market discussed.
Research Objectives
1.To study and analyze the global Immune Globulin Intravenous consumption (value) by key regions/countries, product type and application, history data from 2017 to 2021, and forecast to 2027.
2.To understand the structure of Immune Globulin Intravenous market by identifying its various subsegments.
3.Focuses on the key global Immune Globulin Intravenous manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the Immune Globulin Intravenous with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of Immune Globulin Intravenous submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
Global Immune Globulin Intravenous Market Research Report 2022, Forecast to 2027
1 Market Study Overview
1.1 Study Objectives
1.2 Immune Globulin Intravenous Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research methods
1.5 Market Breakdown and Data Triangulation
2 Global Trend Summary
2.1 Immune Globulin Intravenous Segment by Type
2.1.1 IVIg Liquid
2.1.2 IVIg Powder
2.2 Market Analysis by Application
2.2.1 Immunodeficiency
2.2.2 Autoimmune Disease
2.2.3 Acute Infection
2.3 Global Immune Globulin Intravenous Market Comparison by Regions (2017-2027)
2.3.1 Global Immune Globulin Intravenous Market Size (2017-2027)
2.3.2 North America Immune Globulin Intravenous Status and Prospect (2017-2027)
2.3.3 Europe Immune Globulin Intravenous Status and Prospect (2017-2027)
2.3.4 China Immune Globulin Intravenous Status and Prospect (2017-2027)
2.3.5 Japan Immune Globulin Intravenous Status and Prospect (2017-2027)
2.3.6 Southeast Asia Immune Globulin Intravenous Status and Prospect (2017-2027)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2019 (Covid-19): Immune Globulin Intravenous Industry Impact
2.5.1 Immune Globulin Intravenous Business Impact Assessment - Covid-19
2.5.2 Market Trends and Immune Globulin Intravenous Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19
3 Competition by Manufacturer
3.1 Global Immune Globulin Intravenous Sales and Market Share by Manufacturer (2017-2022)
3.2 Global Immune Globulin Intravenous Revenue and Market Share by Manufacturer (2017-2022)
3.3 Global Immune Globulin Intravenous Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Immune Globulin Intravenous Manufacturer Market Share
3.5 Top 10 Immune Globulin Intravenous Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Immune Globulin Intravenous Market
3.7 Key Manufacturers Immune Globulin Intravenous Key Manufacturers
3.8 Mergers & Acquisitions Planning
4 Analysis of Immune Globulin Intravenous Industry Key Manufacturers
4.1 Baxter
4.1.1 Compan Detail
4.1.2 Baxter Immune Globulin Intravenous Product Introduction, Application and Specification
4.1.3 Baxter 160 Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.1.4 Main Business Overview
4.1.5 Baxter News
4.2 Grifols
4.2.1 Compan Detail
4.2.2 Grifols Immune Globulin Intravenous Product Introduction, Application and Specification
4.2.3 Grifols Immune Globulin Intravenous Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.2.4 Main Business Overview
4.2.5 Baxter News
4.3 CSL
4.3.1 Compan Detail
4.3.2 CSL Immune Globulin Intravenous Product Introduction, Application and Specification
4.3.3 CSL Immune Globulin Intravenous Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.3.4 Main Business Overview
4.3.5 CSL News
4.4 Octapharma
4.4.1 Compan Detail
4.4.2 Octapharma Immune Globulin Intravenous Product Introduction, Application and Specification
4.4.3 Octapharma Immune Globulin Intravenous Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.4.4 Main Business Overview
4.4.5 Octapharma News
4.5 Biotest
4.5.1 Compan Detail
4.5.2 Octapharma Immune Globulin Intravenous Product Introduction, Application and Specification
4.5.3 Biotest Immune Globulin Intravenous Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.5.4 Main Business Overview
4.5.5 Biotest News
4.6 Kedrion
4.6.1 Compan Detail
4.6.2 Kedrion Immune Globulin Intravenous Product Introduction, Application and Specification
4.6.3 Kedrion Immune Globulin Intravenous Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.6.4 Main Business Overview
4.6.5 Kedrion News
4.7 Hualan Bio
4.7.1 Compan Detail
4.7.2 Hualan Bio Immune Globulin Intravenous Product Introduction, Application and Specification
4.7.3 Hualan Bio Immune Globulin Intravenous Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.7.4 Main Business Overview
4.7.4 Main Business Overview
4.8 CNBG
4.8.1 Compan Detail
4.8.2 CNBG Immune Globulin Intravenous Product Introduction, Application and Specification
4.8.3 CNBG Immune Globulin Intravenous Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.8.4 Main Business Overview
4.8.5 CNBG News
4.9 Shanghai RAAS
4.9.1 Compan Detail
4.9.2 Shanghai RAAS Immune Globulin Intravenous Product Introduction, Application and Specification
4.9.3 Shanghai RAAS Immune Globulin Intravenous Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.9.4 Main Business Overview
4.9.5 Shanghai RAAS News
4.10 CBPO
4.10.1 Compan Detail
4.10.2 CBPO Immune Globulin Intravenous Product Introduction, Application and Specification
4.10.3 CBPO Immune Globulin Intravenous Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.10.4 Main Business Overview
4.10.5 CBPO News
4.11 LFB Group
4.11.1 Compan Detail
4.11.2 LFB Group Immune Globulin Intravenous Product Introduction, Application and Specification
4.11.3 LFB Group Immune Globulin Intravenous Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.11.4 Main Business Overview
4.11.5 LFB Group News
4.12 BPL
4.12.1 Compan Detail
4.12.2 BPL Immune Globulin Intravenous Product Introduction, Application and Specification
4.12.3 BPL Immune Globulin Intravenous Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.12.4 Main Business Overview
4.12.5 BPL News
4.13 Sichuan Yuanda Shuyang
4.13.1 Company Details
4.13.2 Sichuan Yuanda Shuyang Immune Globulin Intravenous Product Introduction, Application and Specification
4.13.3 Sichuan Yuanda Shuyang Immune Globulin Intravenous Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.13.4 Main Business Overview
4.13.5 Sichuan Yuanda Shuyang News
5 Global Immune Globulin Intravenous Market Segment by Big Type
5.1 Global Immune Globulin Intravenous Revenue, Sales and Market Share by Big Type (2017-2022)
5.1.1 Global Immune Globulin Intravenous Sales and Market Share by Big Type (2017-2022)
5.1.2 Global Immune Globulin Intravenous Revenue and Market Share by Big Type (2017-2022)
5.2 IVIg Liquid Sales Growth Rate and Price
5.2.1 Global IVIg Liquid Sales Growth Rate (2017-2022)
5.2.2 Global IVIg Liquid Price (2017-2022)
5.3 IVIg Powder Sales Growth Rate and Price
5.3.1 Global IVIg Powder Sales Growth Rate (2017-2022)
5.3.2 Global IVIg Powder Price (2017-2022)
6 Global Immune Globulin Intravenous Market Segment by Big Application
6.1 Global Immune Globulin Intravenous Sales Market Share by Big Application (2017-2022)
6.2 Immunodeficiency Sales Growth Rate (2017-2022)
6.3 Autoimmune Disease Sales Growth Rate (2017-2022)
6.4 Acute Infection Sales Growth Rate (2017-2022)
7 Global Immune Globulin Intravenous Forecast
7.1 Global Immune Globulin Intravenous Revenue, Sales and Growth Rate (2022-2027)
7.2 Immune Globulin Intravenous Market Forecast by Regions (2022-2027)
7.2.1 North America Immune Globulin Intravenous Market Forecast (2022-2027)
7.2.2 Europe Immune Globulin Intravenous Market Forecast (2022-2027)
7.2.3 China Immune Globulin Intravenous Market Forecast (2022-2027)
7.2.4 Japan Immune Globulin Intravenous Market Forecast (2022-2027)
7.2.5 Southeast Asia Immune Globulin Intravenous Market Forecast (2022-2027)
7.2.6 Other Regions Immune Globulin Intravenous Market Forecast (2022-2027)
7.3 Immune Globulin Intravenous Market Forecast by Type (2022-2027)
7.3.1 Global Immune Globulin Intravenous Sales Forecast by Type (2022-2027)
7.3.2 Global Immune Globulin Intravenous Market Share Forecast by Type (2022-2027)
7.4 Immune Globulin Intravenous Market Forecast by Application (2022-2027)
7.4.1 Global Immune Globulin Intravenous Sales Forecast by Application (2022-2027)
7.4.2 Global Immune Globulin Intravenous Market Share Forecast by Application (2022-2027)
8 Market Analysis
8.1.1 Market Overview
8.1.2 Market Opportunities
8.1.3 Market Risk
8.1.4 Market Driving Force
8.1.5 Porter's Five Forces Analysis
8.1.6 SWOT Analysis
9 Immune Globulin Intravenous Related Market Analysis
9.1 Upstream Analysis
9.1.1 Macro Analysis of Upstream Markets
9.1.2 Key Players in Upstream Markets
9.1.3 Upstream Market Trend Analysis
9.1.4 Immune Globulin Intravenous Manufacturing Cost Analysis
9.2 Downstream Market Analysis
9.2.1 Macro Analysis of Down Markets
9.2.2 Key Players in Down Markets
9.2.3 Downstream Market Trend Analysis
9.2.4 Sales Channel, Distributors, Traders and Dealers
10 Research Findings and Conclusion
List of Tables and Figures
Figure Product Picture Immune Globulin Intravenous
Figure Market Concentration Ratio and Market Maturity Analysis of Immune Globulin Intravenous
Figure Bottom-up and Top-down Approaches for This Report
Figure Part of Our External Database
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Immune Globulin Intravenous Market Size by Big Type
Figure Global Market Share of Immune Globulin Intravenous by Big Type in 2021
Figure IVIg Liquid Picture (2017-2022)
Global Immune Globulin Intravenous Market Size by Big Application
Table Global Immune Globulin Intravenous Market Size by Application
Figure Global Immune Globulin Intravenous Market Share by Big Application in 2021
Figure Immunodeficiency Picture
Figure Autoimmune Disease Picture
Figure Acute Infection Picture
Table Global Immune Globulin Intravenous Comparison by Regions (M USD) (2017-2027?
Figure Global Immune Globulin Intravenous Market Size (Million US$) (2017-2027)
Figure North America Immune Globulin Intravenous Revenue (Million US$) Growth Rate (2017-2027)
Figure Europe Immune Globulin Intravenous Revenue (Million US$) Growth Rate (2017-2027)
Figure China Immune Globulin Intravenous Revenue (Million US$) Growth Rate (2017-2027)
Figure Japan Immune Globulin Intravenous Revenue (Million US$) Growth Rate (2017-2027)
Figure Southeast Asia Immune Globulin Intravenous Revenue (Million US$) Growth Rate (2017-2027)
Table Business Impact Assessment - Covid-19
Table Market Trends and Immune Globulin Intravenous Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Immune Globulin Intravenous Sales by Manufacturer (2017-2022)
Figure Global Immune Globulin Intravenous Sales Market Share by Manufacturer in 2021
Table Global Immune Globulin Intravenous Revenue by Manufacturer (2017-2022)
Figure Global Immune Globulin Intravenous Revenue Market Share by Manufacturer in 2021
Table Global Immune Globulin Intravenous Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Immune Globulin Intravenous Manufacturer (Revenue) Market Share in 2021
Figure Top 10 Immune Globulin Intravenous Manufacturer (Revenue) Market Share in 2021
Table Date of Key Manufacturers Enter into Immune Globulin Intravenous Market
Table Key Manufacturers Immune Globulin Intravenous Product Type
Table Mergers & Acquisitions Planning
Table Baxter Company Profile
Table Immune Globulin Intravenous Product Introduction, Application and Specification of Baxter
Table Immune Globulin Intravenous Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company One 2017-2022
Table Company One Main Business
Table Company One Recent Development
Table Grifols Company Profile
Table Immune Globulin Intravenous Product Introduction, Application and Specification of Grifols
Table Immune Globulin Intravenous Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Grifols Recent Development
Table CSL Company Profile
Table Immune Globulin Intravenous Product Introduction, Application and Specification of CSL
Table Immune Globulin Intravenous Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table CSL Main Business
Table CSL Recent Development
Table Octapharma Company Profile
Table Immune Globulin Intravenous Product Introduction, Application and Specification of Octapharma
Table Immune Globulin Intravenous Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Octapharma Main Business
Table Octapharma Recent Development
Table Octapharma Main Business
Table Octapharma Recent Development
Table Biotest Company Profile
Table Immune Globulin Intravenous Product Introduction, Application and Specification of Biotest
Table Immune Globulin Intravenous Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Biotest Main Business
Table Biotest Recent Development
Table Kedrion Company Profile
Table Immune Globulin Intravenous Product Introduction, Application and Specification of Kedrion
Table Immune Globulin Intravenous Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Kedrion Main Business
Table Kedrion Recent Development
Table Hualan Bio Company Profile
Table Immune Globulin Intravenous Product Introduction, Application and Specification of Hualan Bio
Table Immune Globulin Intravenous Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Hualan Bio Main Business
Table Hualan Bio Recent Development
Table CNBG Company Profile
Table Immune Globulin Intravenous Product Introduction, Application and Specification of CNBG
Table Immune Globulin Intravenous Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table CNBG Main Business
Table CNBG Recent Development
Table Shanghai RAAS Company Profile
Table Immune Globulin Intravenous Product Introduction, Application and Specification of Shanghai RAAS
Table Immune Globulin Intravenous Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Shanghai RAAS Main Business
Table Shanghai RAAS Recent Development
Table CBPO Company Profile
Table Immune Globulin Intravenous Product Introduction, Application and Specification of CBPO
Table Immune Globulin Intravenous Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table CBPO Main Business
Table CBPO Recent Development
Table LFB Group Company Profile
Table Immune Globulin Intravenous Product Introduction, Application and Specification of LFB Group
Table Immune Globulin Intravenous Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table LFB Group Main Business
Table LFB Group Recent Development
Table BPL Company Profile
Table Immune Globulin Intravenous Product Introduction, Application and Specification of BPL
Table Immune Globulin Intravenous Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table BPL Main Business
Table BPL Recent Development
Table Sichuan Yuanda Shuyang Company Profile
Table Immune Globulin Intravenous Product Introduction, Application and Specification of Sichuan Yuanda Shuyang
Table Immune Globulin Intravenous Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Sichuan Yuanda Shuyang Main Business
Table Sichuan Yuanda Shuyang Recent Development
Figure Global Immune Globulin Intravenous Sales and Growth Rate (2017-2022)
Figure Global Immune Globulin Intravenous Revenue and Growth Rate (2017-2022)
Table Global Immune Globulin Intravenous Sales by Regions (2017-2022)
Figure Global Immune Globulin Intravenous Sales Market Share by Regions in 2021
Table Global Immune Globulin Intravenous Revenue by Regions (2017-2022)
Figure Global Immune Globulin Intravenous Revenue Market Share by Regions in 2021
Figure North America Immune Globulin Intravenous Sales and Growth Rate (2017-2022)
Figure Europe Immune Globulin Intravenous Sales and Growth Rate (2017-2022)
Figure China Immune Globulin Intravenous Sales and Growth Rate (2017-2022)
Figure Japan Immune Globulin Intravenous Sales and Growth Rate (2017-2022)
Figure Southeast Asia Immune Globulin Intravenous Sales and Growth Rate (2017-2022)
Figure Other Regions Immune Globulin Intravenous Sales and Growth Rate (2017-2022)
Table Global Immune Globulin Intravenous Sales by Big Type (2017-2022)
Table Global Immune Globulin Intravenous Sales Market Share by Big Type (2017-2022)
Figure Global Immune Globulin Intravenous Sales Market Share by Big Type in 2019
Table Global Immune Globulin Intravenous Revenue by Big Type (2017-2022)
Table Global Immune Globulin Intravenous Revenue Market Share by Big Type (2017-2022)
Table Global Immune Globulin Intravenous Revenue Market Share by Big Type in 2019
Figure Global IVIg Liquid Sales Growth Rate (2017-2022)
Figure Global IVIg Liquid Price (2017-2022)
Figure Global IVIg Powder Sales Growth Rate (2017-2022)
Table Global Immune Globulin Intravenous Sales by Big Application (2017-2022)
Table Global Immune Globulin Intravenous Sales Market Share by Big Application (2017-2022)
Figure Global Immune Globulin Intravenous Sales Market Share by Big Application in 2019
Figure Global Immunodeficiency Sales Growth Rate (2017-2022)
Figure Global Autoimmune Disease Sales Growth Rate (2017-2022)
Figure Global Acute Infection Sales Growth Rate (2017-2022)
Figure Global Immune Globulin Intravenous Sales and Growth Rate (2022-2027)
Figure Global Immune Globulin Intravenous Revenue and Growth Rate (2022-2027)
Table Global Immune Globulin Intravenous Sales Forecast by Regions (2022-2027)
Table Global Immune Globulin Intravenous Market Share Forecast by Regions (2022-2027)
Figure North America Sales Immune Globulin Intravenous Market Forecast (2022-2027)
Figure Europe Sales Immune Globulin Intravenous Market Forecast (2022-2027)
Figure China Sales Immune Globulin Intravenous Market Forecast (2022-2027)
Figure Japan Sales Immune Globulin Intravenous Market Forecast (2022-2027)
Figure Southeast Asia Sales Immune Globulin Intravenous Market Forecast (2022-2027)
Figure Other Regions Sales Immune Globulin Intravenous Market Forecast (2022-2027)
Table Global Immune Globulin Intravenous Sales Forecast by Type (2022-2027)
Table Global Immune Globulin Intravenous Market Share Forecast by Type (2022-2027)
Table Global Immune Globulin Intravenous Sales Forecast by Application (2022-2027)
Table Global Immune Globulin Intravenous Market Share Forecast by Application (2022-2027)
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Figure Porter's Five Forces Analysis
Table Macro Analysis of Upstream Markets
Table Key Players in Upstream Markets
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Immune Globulin Intravenous
Table Macro Analysis of Down Markets
Table Key Players in Down Markets
Table Key Players of Downstream Markets
Figure Sales Channel
Figure North America Immune Globulin Intravenous Sales (K Units) Growth Rate Forecast (2021-2025)
Figure North America Immune Globulin Intravenous Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Europe Immune Globulin Intravenous Sales (K Units) Growth Rate Forecast (2021-2025)
Figure Europe Immune Globulin Intravenous Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Japan Immune Globulin Intravenous Production (K Units) Growth Rate Forecast (2021-2025)
Figure Japan Immune Globulin Intravenous Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure China Immune Globulin Intravenous Production (K Units) Growth Rate Forecast (2021-2025)
Figure China Immune Globulin Intravenous Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Methodology/Research Approach
Figure Market Size Estimation
Figure Author List
Baxter
Grifols
CSL
Octapharma
Biotest
Kedrion
Hualan Bio
CNBG
Shanghai RAAS
CBPO
LFB Group
Global Freckle-removing Medical and Beau..
The global market for Freckle-removing Medical and Beauty Eq..
+16467917070US (Toll Free)